(Q42684547)

4 November 2017

Encephalopathy with rapid infusion ifosfamide/mesna (English)

1 reference

4 November 2017

T J Perren

1

1 reference

4 November 2017

R C Turner

series ordinal

2

1 reference

4 November 2017

I E Smith

series ordinal

3

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 February 1987

1 reference

4 November 2017

1 reference

4 November 2017

1

1 reference

4 November 2017

390-391

1 reference

4 November 2017

8529

1 reference

Encephalopathy associated with ifosphamide/mesna therapy

4 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991769-7

7 January 2021

Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991769-7

7 January 2021

High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991769-7

7 January 2021

Dechloroethylation of ifosfamide and neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991769-7

7 January 2021

Prediction of ifosfamide/mesna associated encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991769-7

7 January 2021

Avoiding ifosfamide/mesna encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991769-7

7 January 2021

10.1016/S0140-6736(87)91769-7

Identifiers

DOI

1 reference

4 November 2017

1 reference